Manchester Royal Eye Hospital, UK.
Acta Ophthalmol. 2010 May;88(3):e57-65. doi: 10.1111/j.1755-3768.2010.01877.x. Epub 2010 Mar 8.
To evaluate the perfusion effects and long-term visual outcome of pars plana vitrectomy (PPV) combined with arteriovenous sheathotomy (AVS) with or without triamcinolone for nonischaemic branch retinal vein occlusion (NI-BRVO).
Prospective, interventional case series of eight patients with NI-BRVO and haemorrhagic macular oedema. Patients underwent PPV and AVS (n = 5), or PPV, AVS and intravitreal triamcinolone (IVT, n = 3). A masked grading technique assessed fundus photographs and fluorescein angiography (FFA) following surgery. Scanning laser ophthalmoscopy/optical coherence tomography (SLO/OCT) evaluated macular oedema and outer retinal architecture. Main outcomes examined included visual acuity (VA), retinal reperfusion, collateral vessel regression, vascular dilatation, cystoid macular oedema (CMO), and ocular neovascularization.
Seven of eight patients underwent uncomplicated surgery, with increased intraretinal perfusion and reduced engorgement of distal retinal veins. The mean pre-logMAR VA was 0.8 (SD 0.17) and did not improve significantly after surgery (post-logMAR 0.6, SD 0.38; p = 0.11, paired t-test). SLO/OCT showed persistent CMO in four patients, and subfoveal thinning of the photoreceptor layer. Collateral vessels disappeared at the blockage site post-AVS in 7/8 eyes, and this was associated with improved retinal perfusion. Six of eight patients developed epiretinal membrane. No patients developed ocular neovascularization. The average follow-up was 34.5 months.
PPV with AVS is a safe procedure, and adjunctive IVT had no additional effects on vascular perfusion. Successful decompressive surgery was followed by disappearance of collateral vessels at the BRVO blockage site and was a clinical marker for intravascular reperfusion. Long-term epiretinal gliosis and subfoveal photoreceptor atrophy limited functional and visual recovery.
评估玻璃体切除术(PPV)联合动静脉鞘切开术(AVS)联合或不联合曲安奈德治疗非缺血性分支视网膜静脉阻塞(NI-BRVO)的灌注效果和长期视力结果。
前瞻性、干预性病例系列研究,纳入 8 例 NI-BRVO 合并出血性黄斑水肿患者。患者接受了 PPV 和 AVS(n=5),或 PPV、AVS 和玻璃体内曲安奈德(IVT,n=3)治疗。术后采用盲法分级技术评估眼底照片和荧光素血管造影(FFA)。扫描激光检眼镜/光学相干断层扫描(SLO/OCT)评估黄斑水肿和外视网膜结构。主要观察指标包括视力(VA)、视网膜再灌注、侧支血管消退、血管扩张、囊样黄斑水肿(CMO)和眼内新生血管。
8 例患者中有 7 例手术顺利,视网膜内灌注增加,远端视网膜静脉充盈减少。平均术前 logMAR 视力为 0.8(标准差 0.17),术后无明显改善(术后 logMAR 0.6,标准差 0.38;p=0.11,配对 t 检验)。SLO/OCT 显示 4 例患者存在持续性 CMO 和中心凹下感光细胞层变薄。AVS 后 7/8 只眼阻塞部位的侧支血管消失,视网膜灌注得到改善。8 例患者中有 6 例发生了视网膜内界膜。无患者发生眼内新生血管。平均随访时间为 34.5 个月。
PPV 联合 AVS 是一种安全的手术方法,辅助 IVT 对血管灌注没有额外作用。减压手术后,阻塞部位的侧支血管消失,这是血管再灌注的临床标志物。长期的视网膜内胶质增生和中心凹下感光细胞萎缩限制了功能和视力的恢复。